Pernicious anemia occurs more commonly in people who already have diseases that are linked to immune-system abnormalities, such as Graves disease, hypothyroidism (under-functioning thyroid gland), thyroiditis (inflammation of the thyroid), vitiligo, and Addison's disease (adrenocortical insufficiency)

A Narrative Review of BPC-157 This review found it: Enhances VEGFR2 activity Activates Akt-eNOS pathway Increases nitric oxide production Supports endothelial proliferation and capillary formation Musculoskeletal Repair & Inflammatory Cytokines Emerging Use of BPC-157 in Orthopaedic Sports Medicine Preclinical findings indicate: Enhances growth hormone receptor expression Supports angiogenic signalling pathways Reduces inflammatory cytokine activity Improves structural outcomes in muscle, tendon and ligament injury models Angiogenesis & Antioxidant Pathways Multifunctionality and Possible Medical Application of BPC-157 Findings include: Increased antioxidant protein expression HO-1 and glutathione pathway activation Angiogenic effects in wound healing models Laboratory Stability and Handling Each 10MG vial is supplied in lyophilised form to maintain compound stability during storage and laboratory handling within controlled experimental environments

Jennifer Jose-Cappola, MD helps patients in Stamford and surrounding Stamford achieve sustainable weight loss through advanced metabolic medicine like MIC B12 Injections
To view a copy of this license, visit About this article Cite this article Li, J., Zheng, S., Fan, Y